Auna S.A.: Auna Announces 2Q26 Financial Results

Auna S.A. (NYSE: AUNA) reported 2Q26 results with revenue up 9% FX-neutral to S/1,238 million, but Adjusted EBITDA down 9% FX-neutral to S/227 million. Operating cash flow and free cash flow rose 45% and 181% YoY, respectively. The company attributed EBITDA declines to service mix and cost pressures across its Latin American markets. Auna reaffirmed its full-year revenue guidance of 12% growth and expects Adjusted EBITDA growth at the low end of its 10-14% range.

Original reporting
Published Aug 18, 2026, 9:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 18, 2026, 9:28 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$AUNA
Neutral
medium confidence
Mentioned
$AUNA
Relevance
9/10
AlphAI data visualization · based on finanznachrichten.de
Decision brief

The 30-second read

$AUNANeutralMed
01

Why it matters

The key trade input is the combination of (1) revenue growth, (2) EBITDA margin pressure from service mix and accepted billing-related penalties in Peru, and (3) a strong working-capital-driven cash flow rebound that improves leverage toward a sub-3.0x medium-term target. The company also reaffirms FY26 revenue guidance and provides an EBITDA growth expectation toward the low end.

02

Market read

Traders can update valuation and positioning based on the fresh 2Q26 datapoints and the explicit FY26 revenue and EBITDA outlook framing.

03

What to watch

The guidance for Adjusted EBITDA is framed as low-end growth and explicitly excludes accepted penalties, so the market may scrutinize whether penalties recur or whether cost inflation (pharmacy, payroll, SG&A) persists into 2H26.

Relevance 9/10Novelty 8/10Timing: after-hours results and FY26 guidance reaffirmation for 2Q26

Background

Auna is a Latin America healthcare platform operating in Mexico, Peru, and Colombia, reporting 2Q26 results under IFRS and discussing segment drivers and payor mix.

Company-level read

Ticker impact

$AUNANeutralMedium confidence
Context

Auna reported 2Q26 revenue up 13% YoY and guided FY26 revenue growth near 12% FX-neutral, while Adjusted EBITDA fell on mix and penalties.

Expected impact

Near-term trading likely hinges on whether investors focus on the cash-flow and deleveraging progress versus the EBITDA decline and penalty-driven noise.

Evidence & confidence

The article provides specific 2Q26 KPIs (revenue, Adjusted EBITDA, OCF/FCF, leverage) plus a reaffirmed FY26 revenue guidance and an EBITDA outlook that explicitly reflects temporary cost pressures and excludes accepted penalties.

Market effects

Healthcare services operators in Latin America may see read-across on how risk-sharing (PGP) contract scaling affects margins and working capital.

Peru and Colombia policy and payor mix dynamics are highlighted as influencing predictability and collections, which can affect sentiment toward regional healthcare platforms.

Limited, as the disclosure is company-specific and denominated in Peruvian Soles with FX commentary rather than a global macro shock.

Counterpoint

Investors may discount the EBITDA decline as largely mix and penalty-related, and instead price the deleveraging path and improving collections as the real earnings power signal.

Key entities

  • Auna S.A.

    Announced 2Q26 financial results and reaffirmed FY26 revenue guidance, citing cash-flow strength, leverage improvement, and temporary EBITDA pressure.

Related articles

$AUNAMed

Auna S.A. (AUNA) Stock Falls on Q3 2026 Earnings

Auna S.A. (AUNA) reported Q3 2026 revenue of $384.7M, up 19.4% YoY, with net income falling 57.4% to $5.9M. Operating cash flow rose 38.9% to $77.6M. Insiders made 6 purchases and 1 sale in the past 6 months. Hedge funds showed mixed activity, with some increasing and others decreasing positions.

$AUNAMed

AUNA S.A. (AUNA): Financial results for Q3 2026

AUNA S.A. (AUNA) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Auna Announces 3Q26 Financial Results Auna reports 10% FX-Neutral Revenue Growth and Continued Strong Cash Generation in 3Q2026; Mexico Returns to Year-over-Year Adjusted EBITDA Growth; Profitability Pressured by Specific Headwinds in Colombia and Peru Leverage Impro

$AUNAHigh

Why is Auna stock dropping today?

Auna SAA ADR stock fell 9.2% to $4.91 after revising its 2026 profitability outlook, citing higher cancer diagnosis costs in Colombia. The company maintained its revenue growth target but saw a sell-off amid broader market declines. The stock dropped to a session low of $4.55, nearing its 52-week low of $4.09.

$AUNAMed

Auna (AUNA) Q2 2026 Earnings Call Transcript

Auna (AUNA) reported Q2 2026 results with 9% revenue growth driven by volume and higher complexity services. Adjusted EBITDA declined 9% due to margin pressures in Mexico and Colombia, and billing penalties in Peru. Mexico saw 7% surgery and 20% oncology volume growth, while Peru achieved 8% revenue growth. Colombia's adjusted EBITDA increased 18% sequentially. Leverage decreased to 3.6x, and cash increased 43% year-over-year.